AVROBIO, Inc.
NASDAQ Global SelectTotal Valuation
AVROBIO, Inc. carries a market capitalization of 5.24M, placing it among publicly traded companies globally. Its enterprise value stands at 593.02M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 5.24M |
| Enterprise Value | 593.02M |
Share Statistics
AVROBIO, Inc. currently has 44.88M shares outstanding.
| Shares Outstanding | 44.88M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
AVROBIO, Inc. trades at a trailing price-to-earnings ratio of 22.55.
| PE Ratio | 22.55 |
| PS Ratio | N/A |
| PB Ratio | -1.41 |
| P/TBV Ratio | 7.69 |
| P/FCF Ratio | -13.55 |
| P/OCF Ratio | -13.54 |
Financial Position
AVROBIO, Inc. maintains a current ratio of 26.17, meaning it holds 26.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.25, indicating conservative leverage, while an interest coverage ratio of -109.29 demonstrates limited ability to service its debt obligations.
| Current Ratio | 26.17 |
| Quick Ratio | 25.79 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 0.00 |
| Interest Coverage | -109.29 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 34.57 |
| Return on Invested Capital (ROIC) | -67.82 |
| Return on Capital Employed (ROCE) | -6.29 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
AVROBIO, Inc.'s stock has declined approximately -92.17002% over the past 52 weeks. The 50-day moving average sits at 16.17, while the 200-day moving average is 16.46.
| Beta (5Y) | N/A |
| 52-Week Price Change | -92.17002% |
| 50-Day Moving Average | 16.17 |
| 200-Day Moving Average | 16.46 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -54.10M, while operating income came in at -54.39M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -54.39M |
| Pretax Income | 30.68M |
| Net Income | 30.31M |
| EBITDA | -54.10M |
| EBIT | -54.39M |
| Earnings Per Share (EPS) | 0.68 |
Balance Sheet
AVROBIO, Inc. holds 90.48M in cash and equivalents against 224,000.00 in total debt, resulting in a net debt position of -90.48M. Total book value stands at -484.08M, with working capital of 88.33M providing operational flexibility.
| Cash & Cash Equivalents | 90.48M |
| Total Debt | 224,000.00 |
| Net Debt | -90.48M |
| Equity (Book Value) | -484.08M |
| Book Value Per Share | -10.88 |
| Working Capital | 88.33M |
Cash Flow
AVROBIO, Inc. produced -50.47M in operating cash flow over the past twelve months.
| Operating Cash Flow | -50.47M |
| Capital Expenditures | N/A |
| Free Cash Flow | -50.47M |
| FCF Per Share | -1.13 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 2.35 |
| FCF Yield | -7.38 |
Stock Splits
AVROBIO, Inc.'s most recent stock split took place on June 21, 2024 with a 12:1 split ratio.
| Last Split Date | 6/21/2024 |
| Split Ratio | 12:1 |
Scores
AVROBIO, Inc. posts an Altman Z-Score of 108.70, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 108.70 |